First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

Samuel Cytryn, Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi, Geoffrey Y. Ku, Steven B. Maron, Avni M. Desai, Jessica Yang,

The Lancet Oncology · 2023 · 45 citations · 21 references

DOIFull text

Open access

Concepts

References

21